Global Endowment Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-5,200
| Closed | -$493K | – | 139 |
|
|
2024
Q1 | $493K | Hold |
5,200
| – | – | 0.05% | 109 |
|
|
2023
Q4 | $464K | Hold |
5,200
| – | – | 0.05% | 111 |
|
|
2023
Q3 | $380K | Hold |
5,200
| – | – | 0.04% | 101 |
|
|
2023
Q2 | $433K | Hold |
5,200
| – | – | 0.05% | 65 |
|
|
2023
Q1 | $396K | Sell |
5,200
-11,800
| -69% | -$899K | 0.04% | 86 |
|
|
2022
Q4 | $1.41M | Hold |
17,000
| – | – | 0.16% | 58 |
|
|
2022
Q3 | $1.35M | Hold |
17,000
| – | – | 0.14% | 60 |
|
|
2022
Q2 | $1.26M | Hold |
17,000
| – | – | 0.11% | 73 |
|
|
2022
Q1 | $1.53M | Buy |
+17,000
| New | +$1.53M | 0.11% | 69 |
|